{
  "ticker": "PMC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02978197",
  "id": "02978197",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250807",
  "time": "1751",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250807/pdf/06mnbcrpwrc83n.pdf",
  "summary": "**Monthly Investment Update & NTA Report (31 July 2025) - Key Points:**  \n\n- **Performance:** Portfolio returned **+3.9%** (vs. MSCI AC World Index +3.2%), driven by tech, communications, and healthcare holdings.  \n- **NTA:** Pre-tax NTA **$1.5735**; Post-tax NTA **$1.5226**.  \n- **Dividend Yield:** Current yield **4.23%**; maximum franked dividend **1.75cps**.  \n- **Key Contributors:** Taiwan Semiconductor, Alphabet, Novartis, UBS Group, Shinhan Financial, and new positions (e.g., Rogers Communications).  \n- **Valuation Metrics:** Portfolio trades at a **53% higher earnings yield** (8.1% vs. index 5.3%) and **48% discount on P/B** (1.7x vs. index 3.3x).  \n- **Exposure:** **80.1% net long** (Asia-Pacific 28.5%, Europe 27.6%, North America 21.9%); **19.9% cash**.  \n- **Market Outlook:** Caution on US tariff/employment risks; portfolio diversified across Europe, Asia, and value sectors.  \n\n*(Note: Excluded operational/boilerplate details.)*",
  "usage": {
    "prompt_tokens": 2976,
    "completion_tokens": 283,
    "total_tokens": 3259,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-07T08:21:56.492044"
}